County
Coos County Emergency Medical Services
Drugs and doses48
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 100 |
| Seizure | peds | 15 mg/kg | PO | not captured | standing | pages 74, 100 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 g | PO | not captured | standing | pages 69, 102 |
| Other | adult | 25–50 g | PO | not captured | standing | pages 69, 102 |
| Other | peds | 0.5 g/kg | PO | not captured | standing | pages 69, 102 |
| Other | peds | 0.5 g/kg | PO | not captured | standing | pages 69, 102 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 103 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 103 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 32, 71, 72, 73, 96, 104 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 32, 71, 72, 73, 96, 104 |
| Hyperkalemia | adult | 2.5 mg | NEB | not captured | standing | pages 55, 104 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | pages 55, 104 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 46, 105 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 42, 86, 105 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 42, 86, 105 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 42, 86, 105 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 42, 86, 105 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 38, 101 |
| Other | adult | 324 mg | PO | not captured | standing | pages 33, 101 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 44, 106 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 44, 106 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM/SQ/ET | not captured | standing | pages 69, 106 |
| Organophosphate poisoning | peds | 0.03–0.05 mg/kg | IV/IO/IM/SQ/ET | not captured | standing | pages 69, 106 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 106, 197 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mL | IV | not captured | standing | page 93 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–3 g | IV | not captured | standing | page 107 |
| Hyperkalemia | adult | 1–3 g | IV | not captured | standing | page 107 |
| Other | adult | 1–3 g | IV | not captured | standing | page 107 |
D–F Dextrose, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl, Flumazenil, Furosemide10
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12–48 g | PO | not captured | standing | page 121 |
| Other | adult | 50 mL | IV/IO | not captured | standing | page 121 |
| Other | peds | 0.5 g/kg | PO | not captured | standing | page 121 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 109 |
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 109 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 109 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | page 110 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IO/IM/PO | not captured | standing | page 110 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | page 110 |
| Dystonic reaction | peds | 1–2 mg/kg | IV/IO/IM/PO | not captured | standing | page 110 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 44 |
| Hypotension / shock | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 111 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IO/IM | not captured | standing | page 112 |
| Nausea / vomiting | adult | 1.25 mg | IV/IO/IM | not captured | standing | page 112 |
| Procedural sedation | adult | 2.5 mg | IV/IO/IM | not captured | standing | page 112 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | SQ | not captured | standing | page 113 |
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 113 |
| Anaphylaxis | adult | 0.3–0.5 mg | IV/IO | not captured | standing | page 113 |
| Anaphylaxis | peds | 0.01 mg/kg | SQ | not captured | standing | page 113 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 113 |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 113 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IV/IO | not captured | standing | page 113 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 113 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 113 |
| Cardiac arrest | adult | 2 mg | ET | not captured | standing | page 114 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 113 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 116 |
| Other | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 116 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 117 |
| Burns | peds | 2–3 mcg/kg | IV/IO/IM/IN | not captured | standing | page 117 |
| Other | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 117 |
| Other | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | page 117 |
| Other | peds | 2–3 mcg/kg | IV/IO/IM/IN | not captured | standing | page 117 |
| Other | peds | 2–3 mcg/kg | IV/IO/IM/IN | not captured | standing | page 117 |
Flumazenil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2 mg | IV/IO | not captured | standing | page 118 |
| Other | adult | 0.2 mg | IV/IO | not captured | standing | page 118 |
| Other | adult | 0.2 mg | IV/IO | not captured | standing | page 118 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 118 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 118 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 118 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40–80 mg | IV/IO | not captured | standing | page 119 |
| Other | adult | 40–80 mg | IV/IO | not captured | standing | page 119 |
G–L Glucagon, Haloperidol, Heparin, Hydralazine, Hydromorphone, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM/SQ | not captured | standing | page 120 |
| Other | adult | 3–5 mg | IV/IO | not captured | standing | page 120 |
| Other | peds | 50–150 mcg/kg | IV/IO | not captured | standing | page 120 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IM | not captured | standing | page 122 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg | IV | not captured | standing | page 123 |
Hydralazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV/IO | not captured | standing | page 124 |
| Other | adult | 10–20 mg | IV/IO | not captured | standing | page 124 |
| Other | peds | 0.1–0.5 mg/kg | IV/IO | not captured | standing | page 124 |
| Other | peds | 0.1–0.5 mg/kg | IV/IO | not captured | standing | page 124 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg | IV/IO/IM | not captured | standing | page 125 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 126 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 126 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 126 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 126 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 126 |
| COPD | peds | 0.5 mg | NEB | not captured | standing | page 126 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg/kg | IV/IO | not captured | standing | page 127 |
| Agitation | adult | 5 mg/kg | IM | not captured | standing | page 127 |
| Agitation | peds | 2 mg/kg | IV/IO | not captured | standing | page 127 |
| Agitation | peds | 5 mg/kg | IM | not captured | standing | page 127 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 127 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 127 |
| Mild to moderate pain | adult | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 127 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 127 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV/IO/IM | not captured | standing | page 128 |
| Severe pain | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 128 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 129 |
| Other | adult | 20 mg | IV | not captured | standing | page 129 |
| Other | adult | 20 mg | IV | not captured | standing | page 129 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IO | not captured | standing | page 130 |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 130 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 130 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV/IO | not captured | standing | page 130 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–4 mg | IV/IO/IM | not captured | standing | page 131 |
| Other | adult | 1–4 mg | IV/IO/IM | not captured | standing | page 131 |
| Other | adult | 1–4 mg | IV/IO/IM | not captured | standing | page 131 |
| Seizure | adult | 1–4 mg | IV/IO/IM | not captured | standing | page 131 |
| Seizure | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 131 |
M–O Magnesium Sulfate, Meperidine, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxytocin13
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | pages 93, 132 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | pages 93, 132 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 132 |
| Other | adult | 1–2 g | IV/IO | not captured | standing | page 132 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 132 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 132 |
Meperidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Burns | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Other | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Other | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Other | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Other | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
| Mild to moderate pain | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Mild to moderate pain | adult | 10–25 mg | IV/IO | not captured | standing | page 134 |
| Mild to moderate pain | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
| Mild to moderate pain | peds | 0.5–0.7 mg/kg | IV/IO | not captured | standing | page 134 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| COPD | adult | 125 mg | IV/IO | not captured | standing | page 135 |
| COPD | peds | 2 mg/kg | IV/IO | not captured | standing | page 135 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 135 |
| Other | adult | 125 mg | IV/IO | not captured | standing | page 135 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 135 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 135 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10 mg | IV/IO | not captured | standing | page 136 |
| Other | adult | 10 mg | IV/IO | not captured | standing | page 136 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | page 137 |
| Other | adult | 5 mg | IV | not captured | standing | page 137 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–5 mg | IV/IO/IM/IN | not captured | standing | page 138 |
| Other | adult | 1–5 mg | IV/IO/IM/IN | not captured | standing | page 138 |
| Procedural sedation | adult | 1–5 mg | IV/IO/IM/IN | not captured | standing | page 138 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 138 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg | IV/IO | not captured | standing | page 139 |
| Mild to moderate pain | adult | 6–8 mg | IV/IO | not captured | standing | page 139 |
| Mild to moderate pain | adult | 6–8 mg | IM | not captured | standing | page 139 |
| Mild to moderate pain | peds | 0.05–0.2 mg/kg | IV/IO | not captured | standing | page 139 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IM | not captured | standing | page 139 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4–2 mg | IV/IO/IM/SQ/SL | not captured | standing | page 140 |
| Other | peds | 0.1 mg/kg | IN | not captured | standing | page 140 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/SQ/SL | not captured | standing | page 140 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 141 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 141 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 141 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4–12 mcg | IV | not captured | standing | page 143 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IO/SQ/SL | not captured | standing | page 144 |
| Nausea / vomiting | peds | 4 mg | IV/IO/SQ/SL | not captured | standing | page 144 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12–48 g | PO | not captured | standing | page 121 |
| Hypoglycemia | peds | 0.5 g/kg | PO | not captured | standing | page 121 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10–20 unit | IV | not captured | standing | page 147 |
P–R Promethazine, Racemic Epinephrine2
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IM | not captured | standing | page 148 |
| Nausea / vomiting | adult | 6.25–12.5 mg | IV/IO | not captured | standing | page 148 |
| Nausea / vomiting | peds | 0.25–0.5 mg/kg | IV/IO | not captured | standing | page 148 |
| Nausea / vomiting | peds | 0.5–1 mg/kg | IM | not captured | standing | page 148 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mL | NEB | not captured | standing | page 149 |
| Anaphylaxis | peds | 0.5 mL | NEB | not captured | standing | page 149 |
| Other | adult | 0.5 mL | NEB | not captured | standing | page 149 |
| Other | peds | 0.5 mL | NEB | not captured | standing | page 149 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–1.5 mg/kg | IV/IO/IM | not captured | standing | pages 152, 173, 197 |
| RSI induction | peds | 1–1.5 mg/kg | IV/IO/IM | not captured | standing | pages 152, 173, 197 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 153 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 153 |
Cite this
Coos County Emergency Medical Services, United States EMS Protocol Census. 177 dose entries, effective 2025-01-01.
https://protoquiz.com/census/agencies/coos-county-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.